Patents by Inventor Bo Kyung SON

Bo Kyung SON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951130
    Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: April 9, 2024
    Assignee: Eutilex Co., Ltd.
    Inventors: Byoung S. Kwon, Young Ho Kim, Kwang Hee Kim, Ji Won Chung, Young Gyoon Chang, Bo Rim Yi, Jung Yun Lee, Seung Hyun Lee, Sun Woo Im, Jin Kyung Choi, Hyun Tae Son, Eun Hye Yoo
  • Patent number: 9956256
    Abstract: The present invention relates to a novel bacteriophage ?CJ26 (KCCM11464P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by Salmonella by using the bacteriophage ?CJ26 (KCCM11464P) or the composition.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: May 1, 2018
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Bo Kyung Son, Gi Duk Bae, Jae Won Kim
  • Patent number: 9758767
    Abstract: Provided is a novel bacteriophage ?CJ22 (KCCM11364P). In addition, provided is an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases caused by Clostridium perfringens in animals except for humans by using the bacteriophage ?CJ22 (KCCM11364P) or an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: September 12, 2017
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Bo Kyung Son, Gi Duk Bae, Jae Won Kim
  • Patent number: 9745555
    Abstract: Provided is a novel bacteriophage ?CJ21 (KCCM11363P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by Clostridium perfringens in animals except for humans using the bacteriophage ?CJ21 (KCCM11363P) or the antibacterial composition containing the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: August 29, 2017
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Bo Kyung Son, Gi Duk Bae, Jae Won Kim
  • Publication number: 20170189460
    Abstract: The present invention relates to a novel bacteriophage ?CJ26 (KCCM11464P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by Salmonella by using the bacteriophage ?CJ26 (KCCM11464P) or the composition.
    Type: Application
    Filed: April 14, 2015
    Publication date: July 6, 2017
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Bo Kyung SON, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160076003
    Abstract: Provided is a novel bacteriophage ?CJ22 (KCCM11364P). In addition, provided is an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases caused by Clostridium perfringens in animals except for humans by using the bacteriophage ?CJ22 (KCCM11364P) or an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient.
    Type: Application
    Filed: February 26, 2014
    Publication date: March 17, 2016
    Inventors: Bo Kyung SON, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160076004
    Abstract: Provided is a novel bacteriophage ?CJ21 (KCCM11363P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by Clostridium perfringens in animals except for humans using the bacteriophage ?CJ21 (KCCM11363P) or the antibacterial composition containing the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient.
    Type: Application
    Filed: February 26, 2014
    Publication date: March 17, 2016
    Inventors: Bo Kyung SON, Gi Duk BAE, Jae Won KIM